Actas dermo-sifiliograficas最新文献

筛选
英文 中文
Backhaus Towel Clamps: A Noble Ally in the Operating Room Backhaus毛巾夹:手术室的高贵盟友。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-12 DOI: 10.1016/j.ad.2025.104559
A. Bennassar Vicens
{"title":"Backhaus Towel Clamps: A Noble Ally in the Operating Room","authors":"A. Bennassar Vicens","doi":"10.1016/j.ad.2025.104559","DOIUrl":"10.1016/j.ad.2025.104559","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104559"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survey of Usual Clinical Practice in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab Regarding the Management of Antihistamines 奥玛珠单抗治疗慢性自发性荨麻疹患者抗组胺药管理的临床调查
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-11 DOI: 10.1016/j.ad.2025.104549
E. Gómez de la Fuente , F.J. Ortiz de Frutos , M. Bergón Sendín , G. Melé Ninot
{"title":"Survey of Usual Clinical Practice in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab Regarding the Management of Antihistamines","authors":"E. Gómez de la Fuente , F.J. Ortiz de Frutos , M. Bergón Sendín , G. Melé Ninot","doi":"10.1016/j.ad.2025.104549","DOIUrl":"10.1016/j.ad.2025.104549","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104549"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Syndrome With an Unusual Presentation 一种表现不寻常的综合症。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-10 DOI: 10.1016/j.ad.2025.104547
P. Andres-Ibarrola, J. Ugedo Alzaga, M.R. Gonzalez-Hermosa
{"title":"A Syndrome With an Unusual Presentation","authors":"P. Andres-Ibarrola, J. Ugedo Alzaga, M.R. Gonzalez-Hermosa","doi":"10.1016/j.ad.2025.104547","DOIUrl":"10.1016/j.ad.2025.104547","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104547"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Pruritic Papules on Bilateral Auricular Concha 双侧耳甲多发瘙痒丘疹。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-10 DOI: 10.1016/j.ad.2025.104552
S. Romero-Romero , M. Iglesias-Sancho , N. Pérez Muñoz
{"title":"Multiple Pruritic Papules on Bilateral Auricular Concha","authors":"S. Romero-Romero , M. Iglesias-Sancho , N. Pérez Muñoz","doi":"10.1016/j.ad.2025.104552","DOIUrl":"10.1016/j.ad.2025.104552","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104552"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RF-New Treatments in Dermatomyositis: Present and Future 皮肌炎的新治疗方法:现在和未来。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-08 DOI: 10.1016/j.ad.2025.104551
M. Mansilla-Polo , P. Balado-Simó , J.M. Mascaró Jr.
{"title":"RF-New Treatments in Dermatomyositis: Present and Future","authors":"M. Mansilla-Polo , P. Balado-Simó , J.M. Mascaró Jr.","doi":"10.1016/j.ad.2025.104551","DOIUrl":"10.1016/j.ad.2025.104551","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104551"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Roflumilast for Long-term Management of Behçet Spectrum Disorders: A Multicenter Observational Analysis 口服罗氟司特长期治疗行为障碍:一项多中心观察分析。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-12 DOI: 10.1016/j.ad.2025.104561
R. Peñuelas Leal , J.A. Peñuelas Ruiz , Á. González García , L. Bagan , C. Labrandero Hoyos , A. Grau Echevarría , V. Zaragoza Ninet , G. Pérez Pastor , L. García Fernández , M. Linares Barrios , D. Blaya Imbernon , M. Finello , E. Perez Zafrilla , E. Diez Recio , M. Marti Cabrera , J. Bagan , V. Alegre De Miquel
{"title":"Oral Roflumilast for Long-term Management of Behçet Spectrum Disorders: A Multicenter Observational Analysis","authors":"R. Peñuelas Leal ,&nbsp;J.A. Peñuelas Ruiz ,&nbsp;Á. González García ,&nbsp;L. Bagan ,&nbsp;C. Labrandero Hoyos ,&nbsp;A. Grau Echevarría ,&nbsp;V. Zaragoza Ninet ,&nbsp;G. Pérez Pastor ,&nbsp;L. García Fernández ,&nbsp;M. Linares Barrios ,&nbsp;D. Blaya Imbernon ,&nbsp;M. Finello ,&nbsp;E. Perez Zafrilla ,&nbsp;E. Diez Recio ,&nbsp;M. Marti Cabrera ,&nbsp;J. Bagan ,&nbsp;V. Alegre De Miquel","doi":"10.1016/j.ad.2025.104561","DOIUrl":"10.1016/j.ad.2025.104561","url":null,"abstract":"<div><h3>Background</h3><div>Recurrent aphthous stomatitis (RAS) and Behçet's disease (BD) are part of the Behçet spectrum disorders (BSD), sharing genetic traits and characterized by recurrent ulcers. No systemic treatment is approved for RAS or incomplete BD, despite significant quality-of-life impacts.</div></div><div><h3>Objective</h3><div>To evaluate the efficacy of roflumilast, a PDE4 inhibitor, in BSD patients and compare responses between RAS and BD.</div></div><div><h3>Methods</h3><div>This analytical observational study included a total of 33 patients with BSD (22, RAS; 11, BD) from 5 Spanish centers, followed over 52 weeks. Data were collected retrospectively and prospectively, assessing flare-ups, ulcers, pain, and duration. Statistical models compared outcomes across treatment periods.</div></div><div><h3>Results</h3><div>Roflumilast significantly reduced all studied response variables, with no loss of long-term efficacy. Differences between RAS and BD were minimal and clinically irrelevant. Adverse events occurred in 63% of patients, mostly mild and self-limiting, with tolerability improved through dose adjustments. Two patients (6.25%) dropped out due to adverse events.</div></div><div><h3>Conclusion</h3><div>Roflumilast is effective for managing BSD, offering a safe option to address unmet needs in RAS and BD. Its favorable safety profile and long-term efficacy support its use in the routine clinical practice.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104561"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Panniculitis Associated With the Diphtheria–Tetanus–Pertussis Vaccine 白喉-破伤风-百日咳三联疫苗引起的全身炎。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-13 DOI: 10.1016/j.ad.2025.104556
Fatima-zahra Agharbi, Ghita Basri, Inas Chikhaoui, Abderrahmane Albouzidi, Mohammed Oukabli, Soumiya Chiheb
{"title":"Panniculitis Associated With the Diphtheria–Tetanus–Pertussis Vaccine","authors":"Fatima-zahra Agharbi,&nbsp;Ghita Basri,&nbsp;Inas Chikhaoui,&nbsp;Abderrahmane Albouzidi,&nbsp;Mohammed Oukabli,&nbsp;Soumiya Chiheb","doi":"10.1016/j.ad.2025.104556","DOIUrl":"10.1016/j.ad.2025.104556","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104556"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous Pili Migrans 皮肤毛移位。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-08 DOI: 10.1016/j.ad.2025.104550
P. López Sanz, M.E. Alfaro Martínez, S. Manso Córdoba
{"title":"Cutaneous Pili Migrans","authors":"P. López Sanz,&nbsp;M.E. Alfaro Martínez,&nbsp;S. Manso Córdoba","doi":"10.1016/j.ad.2025.104550","DOIUrl":"10.1016/j.ad.2025.104550","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104550"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissecting Cellulitis Associated With Hormone Therapy in a Transgender Man 一名跨性别男性的夹层蜂窝织炎与激素治疗相关。
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-13 DOI: 10.1016/j.ad.2025.104555
J.L. Rodrigues Machado , M. Domingos Almeida , R.F. Cortez de Almeida , D. Fernandes Melo
{"title":"Dissecting Cellulitis Associated With Hormone Therapy in a Transgender Man","authors":"J.L. Rodrigues Machado ,&nbsp;M. Domingos Almeida ,&nbsp;R.F. Cortez de Almeida ,&nbsp;D. Fernandes Melo","doi":"10.1016/j.ad.2025.104555","DOIUrl":"10.1016/j.ad.2025.104555","url":null,"abstract":"","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104555"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From Spain 杜匹单抗治疗特应性皮炎的长期持久性、安全性和有效性:一项来自西班牙的真实世界回顾性多中心研究
IF 2.8
Actas dermo-sifiliograficas Pub Date : 2026-04-01 Epub Date: 2025-12-13 DOI: 10.1016/j.ad.2025.104563
J.F. Silvestre-Salvador , S. Santos-Alarcón , A. Mengual-Sendra , V. Zaragoza-Ninet , M.P. Ortega-García , M. Rodriguez , E. Monte-Boquet , R.F. Ruiz de Apodaca , N. Pérez Prior , F.J. Miquel-Miquel , J. Borras-Blasco
{"title":"Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From Spain","authors":"J.F. Silvestre-Salvador ,&nbsp;S. Santos-Alarcón ,&nbsp;A. Mengual-Sendra ,&nbsp;V. Zaragoza-Ninet ,&nbsp;M.P. Ortega-García ,&nbsp;M. Rodriguez ,&nbsp;E. Monte-Boquet ,&nbsp;R.F. Ruiz de Apodaca ,&nbsp;N. Pérez Prior ,&nbsp;F.J. Miquel-Miquel ,&nbsp;J. Borras-Blasco","doi":"10.1016/j.ad.2025.104563","DOIUrl":"10.1016/j.ad.2025.104563","url":null,"abstract":"<div><h3>Background</h3><div>The safety and efficacy profile of dupilumab in the management of atopic dermatitis (AD) are established in clinical trials. However, long-term real-world persistence data in Spain are limited.</div></div><div><h3>Objective</h3><div>The primary endpoint of the study was to assess the 4-year persistence of dupilumab in routine clinical practice in patients with moderate-to-severe AD. Secondary endpoints included the analysis of safety and efficacy profile during the same period of time.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of dispensation registries and health records from 5 hospitals. Adults with moderate-to-severe AD starting on dupilumab treatment were followed for 4-years. Dupilumab persistence was estimated using Kaplan–Meier analysis. Efficacy was measured by changes in EASI and IGA scores. Significant adverse events (AEs) leading to discontinuation were recorded.</div></div><div><h3>Results</h3><div>A total of 251 patients included (mean age, 46 years; 59.4%, men; 64.5% with at least 1 atopic comorbidity; mean time from AD diagnosis, 14.5 years). Of these, 196 (78.1%) had been on ≥2 systemic therapies before starting dupilumab. Baseline EASI and IGA values averaged 27.9 and 4.0, respectively. Persistence rates were 90%, 80%, 78%, and 73% after 1, 2, 3, and 4-years, respectively. By 16 weeks, 47.8% and 54.7% of patients achieved EASI ≤3 or IGA ≤1, increasing to 76.3% and 77.2% by 52 weeks, and reaching 90.9% in the group followed for &gt;3 years. A total of 38 patients (13.5%) discontinued dupilumab, mainly due to inefficacy (5.6%) and AEs (1.2%).</div></div><div><h3>Conclusion</h3><div>Dupilumab effectively reduced AD severity within the first few weeks, with most patients achieving mild/minimal disease activity or complete clearance by year 1. The observed safety profile was consistent with known data. High persistence rates up to 4-years suggest satisfaction with dupilumab long-term safety and efficacy profile in managing moderate-to-severe AD.</div></div>","PeriodicalId":7173,"journal":{"name":"Actas dermo-sifiliograficas","volume":"117 4","pages":"Article 104563"},"PeriodicalIF":2.8,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书